Institute of Molecular Medicine, Renji Hospital, School of Medicine and School of Chemistry and Chemical Engineering, Shanghai Jiao Tong University , Shanghai 200127, China.
Division of Physical Biology and Bioimaging Center, Shanghai Synchrotron Radiation Facility, Shanghai Institute of Applied Physics, Chinese Academy of Sciences , Shanghai 201800, China.
Nano Lett. 2017 Sep 13;17(9):5193-5198. doi: 10.1021/acs.nanolett.7b01006. Epub 2017 Aug 10.
Circulating tumor cells (CTCs) contain molecular information on the primary tumor and can be used for predictive cancer diagnostics. Capturing rare live CTCs and their quantification in whole blood remain technically challenging. Here we report an aptamer-trigger clamped hybridization chain reaction (atcHCR) method for in situ identification and subsequent cloaking/decloaking of CTCs by porous DNA hydrogels. These decloaked CTCs were then used for live cell analysis. In our design, a DNA staple strand with aptamer-toehold biblocks specifically recognizes epithelial cell adhesion molecule (EpCAM) on the CTC surface that triggers subsequent atcHCR via toehold-initiated branch migration. Porous DNA hydrogel based-cloaking of single/cluster of CTCs allows capturing of living CTCs directly with minimal cell damage. The ability to identify a low number of CTCs in whole blood by DNA hydrogel cloaking would allow high sensitivity and specificity for diagnosis in clinically relevant settings. More significantly, decloaking of CTCs using controlled and defined chemical stimuli can release living CTCs without damages for subsequent culture and live cell analysis. We expect this liquid biopsy tool to open new powerful and effective routes for cancer diagnostics and therapeutics.
循环肿瘤细胞(CTCs)包含原发性肿瘤的分子信息,可用于预测癌症诊断。从全血中捕获罕见的活 CTC 并对其进行定量仍然具有技术挑战性。在这里,我们报告了一种适体触发夹合杂交链式反应(atcHCR)方法,用于通过多孔 DNA 水凝胶原位鉴定和随后的 CTC 屏蔽/去屏蔽。然后,将这些去屏蔽的 CTC 用于活细胞分析。在我们的设计中,具有适体-toehold 双模块的 DNA 订书钉链特异性识别 CTC 表面上的上皮细胞黏附分子(EpCAM),通过 toehold 引发的分支迁移触发随后的 atcHCR。基于多孔 DNA 水凝胶的单个/CTC 簇的屏蔽允许直接捕获活的 CTC,对细胞的损伤最小。通过 DNA 水凝胶屏蔽在全血中识别少量 CTC 的能力将允许在临床相关环境中进行高灵敏度和特异性诊断。更重要的是,使用受控和定义的化学刺激物对 CTC 进行去屏蔽可以在不造成损伤的情况下释放活的 CTC,用于随后的培养和活细胞分析。我们期望这个液体活检工具为癌症诊断和治疗开辟新的强大而有效的途径。